Score: 0%
ORTHOPEDICS HYPERGUIDE MCQ 901-950
QUESTION 1
Which of the following factors most likely has a role in the production of osteoblastic bone metastases:
1
Receptor activator of nuclear factor-kB ligand (RANKL)
2
Parathyroid hormone-related protein (PTHrP)
3
Osteoprotegerin (OPG)
4
Endothelin-1
5
Macrophage inflammatory protein (MIP) 1 alpha
Endothelin-1 likely plays a major role in blastic metastases in breast and prostate cancers. Endothelin-1 stimulates bone formation and the proliferation of osteoblasts.
The mechanism of bone formation is not nearly as well defined as bone destruction in metastatic bone disease. Correct Answe Endothelin-1
The mechanism of bone formation is not nearly as well defined as bone destruction in metastatic bone disease. Correct Answe Endothelin-1
QUESTION 2
Which of the following is a marker for osteoclastic activity:
1
Serum bone specific alkaline phosphatase
2
Serum osteocalcin
3
Serum type 1 procollagen C -propeptide
4
Urine type 1 collagen cross-linked N-telopeptides
5
Serum endothelin-1
The markers of osteoclastic activity are:
Serum C -terminal telopeptide of type 1 collagen
Serum tartrate resistant acid phosphatase
Urine type 1 collagen cross-linked N-telopeptides
Urine C -terminal telopeptide of type 1 collagen
The markers of osteoblastic activity are:
Serum bone specific alkaline phosphatase
Serum osteocalcin
Serum type 1 procollagen C -propeptide
Serum endothelin-1
C orrect Answer: Urine type 1 collagen cross-linked N-telopeptides
Serum C -terminal telopeptide of type 1 collagen
Serum tartrate resistant acid phosphatase
Urine type 1 collagen cross-linked N-telopeptides
Urine C -terminal telopeptide of type 1 collagen
The markers of osteoblastic activity are:
Serum bone specific alkaline phosphatase
Serum osteocalcin
Serum type 1 procollagen C -propeptide
Serum endothelin-1
C orrect Answer: Urine type 1 collagen cross-linked N-telopeptides
QUESTION 3
Which of the following is a marker for osteoblastic activity:
1
Serum C -terminal telopeptide of type-1 collagen
2
Serum tartrate resistant acid phosphatase
3
Urine type-1 collagen cross linked N-telopeptides
4
Urine C -terminal telopeptide of type 1 collagen
5
Serum osteocalcin
The markers of osteoclastic activity are:
Serum C -terminal telopeptide of type 1 collagen
Serum tartrate resistant acid phosphatase
Urine type 1 collagen cross-linked N-telopeptides
Urine C -terminal telopeptide of type 1 collagen
The markers of osteoblastic activity are:
Serum bone specific alkaline phosphatase
Serum osteocalcin
Serum type 1 procollagen C -propeptide
Serum endothelin-1
C orrect Answer: Serum osteocalcin
Serum C -terminal telopeptide of type 1 collagen
Serum tartrate resistant acid phosphatase
Urine type 1 collagen cross-linked N-telopeptides
Urine C -terminal telopeptide of type 1 collagen
The markers of osteoblastic activity are:
Serum bone specific alkaline phosphatase
Serum osteocalcin
Serum type 1 procollagen C -propeptide
Serum endothelin-1
C orrect Answer: Serum osteocalcin
QUESTION 4
Which of the following is a marker for osteoblastic activity:
1
Serum C -terminal telopeptide of type 1 collagen
2
Serum tartrate resistant acid phosphatase
3
Urine type 1 collagen cross-linked N-telopeptides
4
Urine C -terminal telopeptide of type 1 collagen
5
Serum endothelin-1
The markers of osteoclastic activity are:
Serum C -terminal telopeptide of type 1 collagen
Serum tartrate resistant acid phosphatase
Urine type 1 collagen cross-linked N-telopeptides
Urine C -terminal telopeptide of type 1 collagen
The markers of osteoblastic activity are:
Serum bone specific alkaline phosphatase
Serum osteocalcin
Serum type 1 procollagen C -propeptide
Serum endothelin-1
C orrect Answer: Serum endothelin-1
Serum C -terminal telopeptide of type 1 collagen
Serum tartrate resistant acid phosphatase
Urine type 1 collagen cross-linked N-telopeptides
Urine C -terminal telopeptide of type 1 collagen
The markers of osteoblastic activity are:
Serum bone specific alkaline phosphatase
Serum osteocalcin
Serum type 1 procollagen C -propeptide
Serum endothelin-1
C orrect Answer: Serum endothelin-1
QUESTION 5
A patientâs upper extremity radiographs are shown in Slide 1 and Slide 2. The most likely diagnosis is:
1
Enchondromatosis
2
Eosinophilic granuloma
3
Multiple hereditary exostoses
4
Fibrous dysplasia
5
Spondyloepiphyseal dysplasia
This patient has multiple hereditary exostoses. Note the multiple sessile osteochondromas on the humerus and ulna. A
characteristic bowing deformity of the forearm and pseudo-Madelung deformity of the wrist are also present.
Multiple hereditary exostoses is autosomal dominant. The putative tumor suppressive gene mutation is EXT1, EXT2. The risk of low-grade chondrosarcoma occurring is approximately 10%.
In most patients, the forearm deformity does not cause a major problem and can be treated nonoperatively. Correct Answe Multiple hereditary exostoses
characteristic bowing deformity of the forearm and pseudo-Madelung deformity of the wrist are also present.
Multiple hereditary exostoses is autosomal dominant. The putative tumor suppressive gene mutation is EXT1, EXT2. The risk of low-grade chondrosarcoma occurring is approximately 10%.
In most patients, the forearm deformity does not cause a major problem and can be treated nonoperatively. Correct Answe Multiple hereditary exostoses
QUESTION 6
slide 1 slide 2
A patientâs upper extremity radiographs are shown in Slide 1 and Slide 2. What is the most likely inheritance pattern of this condition:
A patientâs upper extremity radiographs are shown in Slide 1 and Slide 2. What is the most likely inheritance pattern of this condition:
1
X-linked recessive
2
X-linked dominant
3
Autosomal recessive
4
Autosomal dominant
5
Sporadic
This patient has multiple hereditary exostoses. Note the multiple sessile osteochondromas on the humerus and ulna. A
characteristic bowing deformity of the forearm and pseudo-Madelung deformity of the wrist are also present.
Multiple hereditary exostoses is autosomal dominant. The putative tumor suppressive gene mutation is EXT1, EXT2. The risk of low-grade chondrosarcoma occurring is approximately 10%.
In most patients, the forearm deformity does not cause a major problem and can be treated nonoperatively. Correct Answe Autosomal dominant
characteristic bowing deformity of the forearm and pseudo-Madelung deformity of the wrist are also present.
Multiple hereditary exostoses is autosomal dominant. The putative tumor suppressive gene mutation is EXT1, EXT2. The risk of low-grade chondrosarcoma occurring is approximately 10%.
In most patients, the forearm deformity does not cause a major problem and can be treated nonoperatively. Correct Answe Autosomal dominant
QUESTION 7
slide 1 slide 2
A patientâs upper extremity radiographs are shown in Slide 1 and Slide 2. Which of the following tumor suppressor genes is most likely involved:
A patientâs upper extremity radiographs are shown in Slide 1 and Slide 2. Which of the following tumor suppressor genes is most likely involved:
1
Retinoblastoma (RB)
2
p53
3
P16INK4A
4
NF1
5
EXT1
This patient has multiple hereditary exostoses. Note the multiple sessile osteochondromas on the humerus and ulna. A
characteristic bowing deformity of the forearm and pseudo-Madelung deformity of the wrist are also present.
Multiple hereditary exostoses is autosomal dominant. The putative tumor suppressive gene mutation is EXT1, EXT2. The risk of low-grade chondrosarcoma occurring is approximately 10%.
In most patients, the forearm deformity does not cause a major problem and can be treated nonoperatively. Correct Answe EXT1
characteristic bowing deformity of the forearm and pseudo-Madelung deformity of the wrist are also present.
Multiple hereditary exostoses is autosomal dominant. The putative tumor suppressive gene mutation is EXT1, EXT2. The risk of low-grade chondrosarcoma occurring is approximately 10%.
In most patients, the forearm deformity does not cause a major problem and can be treated nonoperatively. Correct Answe EXT1
QUESTION 8
slide 1 slide 2
A patientâs upper extremity radiographs are shown in Slide 1 and Slide 2. The risk of malignancy in this condition is approximately:
A patientâs upper extremity radiographs are shown in Slide 1 and Slide 2. The risk of malignancy in this condition is approximately:
1
No risk of malignancy
2
5% to 10%
3
25%
4
50%
5
100%
This patient has multiple hereditary exostoses. Note the multiple sessile osteochondromas on the humerus and ulna. A
characteristic bowing deformity of the forearm and pseudo-Madelung deformity of the wrist are also present.
Multiple hereditary exostoses is autosomal dominant. The putative tumor suppressive gene mutation is EXT1, EXT2. The risk of low-grade chondrosarcoma occurring is approximately 10%.
In most patients, the forearm deformity does not cause a major problem and can be treated nonoperatively. Correct Answe 5% to 10%
characteristic bowing deformity of the forearm and pseudo-Madelung deformity of the wrist are also present.
Multiple hereditary exostoses is autosomal dominant. The putative tumor suppressive gene mutation is EXT1, EXT2. The risk of low-grade chondrosarcoma occurring is approximately 10%.
In most patients, the forearm deformity does not cause a major problem and can be treated nonoperatively. Correct Answe 5% to 10%
QUESTION 9
Which of the following is an indication for surgery in patients with rheumatoid arthritis of the spine:
1
Posterior atlantodental interval between 14 mm and 16 mm
2
Atlantodental interval >5 mm
3
C ervico-medullary angle between 135° and 175°
4
Odontoid migration of 4 mm above McGregorâs line
5
Posterior atlantodental interval of 13 mm with subaxial subluxation
The review article by Kim and Hilibrand summarized the current indications for decompression and fusion in patients with rheumatoid arthritis and cervical spine disease.
The indications are:
A. Progressive neurologic deficit
1/. Myelopathy â wide-based spastic gait, clumsy hands, change in handwriting, difficulty with fine motor control
B. Severe neck pain with atlantoaxial subluxation, atlantoaxial impaction, or subaxial subluxation
C . Atlantoaxial subluxation with a posterior atlantodental interval of 5 mm above McGregorâs line E. Subaxial subluxation with a sagittal canal diameter 10 mm Recovery of at least one Ranawat grade
>14 mm C omplete recovery
C orrect Answer:
.v4b{border:2px solid #0984e3;background:#fff;color:#0984e3;padding:8px 20px;border-radius:25px;cursor:pointer;margin-right:10px;font-weight:bold;transition:0.3s;}
.v4b.active{background:#0984e3;color:#fff;}
.v4b:hover:not(.active){background:#e3f2fd;}
.mcq-v4-card{background:#fff;border-radius:15px;padding:35px;margin-bottom:40px;border:1px solid #e1e8ed;box-shadow:0 5px 15px rgba(0,0,0,0.04);}
.card-meta{color:#0984e3;font-weight:800;margin-bottom:20px;letter-spacing:1.5px;font-size:0.95rem;}
.q-stem{font-size:1.25rem;margin-bottom:30px;font-weight:500;line-height:1.7;color:#2d3436;}
.q-opt{display:flex;align-items:center;padding:15px;border:2px solid #f1f2f6;border-radius:12px;margin-bottom:15px;cursor:pointer;transition:all 0.2s ease-in-out;background:#fff;}
.q-opt:hover{border-color:#0984e3;background:#f0f7ff;transform:translateX(5px);}
.q-opt-circle{width:35px;height:35px;border:2px solid #ddd;border-radius:50%;display:flex;align-items:center;justify-content:center;margin-right:20px;font-weight:bold;background:#fafafa;flex-shrink:0;color:#636e72;}
.q-opt.correct{background:#e3fcef;border-color:#00b894;}
.q-opt.correct .q-opt-circle{background:#00b894;color:#fff;border-color:#00b894;}
.q-opt.wrong{background:#fff5f5;border-color:#ff7675;}
.q-opt.wrong .q-opt-circle{background:#ff7675;color:#fff;border-color:#ff7675;}
.q-opt.selected{border-color:#0984e3;background:#e3f2fd;}
.q-opt.selected .q-opt-circle{background:#0984e3;color:#fff;border-color:#0984e3;}
.q-feedback{margin-top:30px;padding:25px;background:#f8f9fa;border-left:6px solid #0984e3;border-radius:8px;}
.feedback-label{font-weight:bold;margin-bottom:15px;font-size:1.2rem;}
.explanation-text{line-height:1.7;color:#444;font-size:1.05rem;}
var v4E={
m:'study',r:new Map(),
setMode:function(m){this.m=m;document.getElementById('v4s').classList.toggle('active',m=='study');document.getElementById('v4e').classList.toggle('active',m=='exam');document.getElementById('v4xa').style.display=m=='exam'?'block':'none';this.reset();},
reset:function(){document.querySelectorAll('.q-opt').forEach(e=>{e.className='q-opt';e.style.pointerEvents='auto';});document.querySelectorAll('.q-feedback').forEach(e=>e.style.display='none');this.r.clear();this.up();},
up:function(){let s=0;this.r.forEach(v=>{if(v===true||v.s==v.c)s++;});const t=document.querySelectorAll('.mcq-v4-card').length;document.getElementById('v4sc').innerText=Math.round((s/t)*100)||0;},
reveal:function(c,s,k){const o=c.querySelectorAll('.q-opt');if(o[k-1])o[k-1].classList.add('correct');if(s!=k && o[s-1])o[s-1].classList.add('wrong');c.querySelector('.q-feedback').style.display='block';const fl=c.querySelector('.feedback-label');fl.innerHTML=s==k?' Correct Answer':' Incorrect';},
finish:function(){this.r.forEach((v,k)=>{this.reveal(document.getElementById('card-'+k),v.s,v.c);});document.querySelectorAll('.q-opt').forEach(e=>e.style.pointerEvents='none');window.scrollTo({top:0,behavior:'smooth'});}
};
document.querySelectorAll('.q-opt').forEach(el=>{
el.onclick=function(){
const q=this.dataset.q,k=this.dataset.correct,s=this.dataset.idx,p=this.closest('.mcq-v4-card');
if(v4E.m=='study') { if(v4E.r.has(q))return; v4E.r.set(q,s==k); p.querySelectorAll('.q-opt').forEach(o=>o.style.pointerEvents='none'); v4E.reveal(p,s,k); }
else { p.querySelectorAll('.q-opt').forEach(o=>o.classList.remove('selected')); this.classList.add('selected'); v4E.r.set(q,{s:s,c:k}); }
v4E.up();
};
});
The indications are:
A. Progressive neurologic deficit
1/. Myelopathy â wide-based spastic gait, clumsy hands, change in handwriting, difficulty with fine motor control
B. Severe neck pain with atlantoaxial subluxation, atlantoaxial impaction, or subaxial subluxation
C . Atlantoaxial subluxation with a posterior atlantodental interval of 5 mm above McGregorâs line E. Subaxial subluxation with a sagittal canal diameter 10 mm Recovery of at least one Ranawat grade
>14 mm C omplete recovery
C orrect Answer:
.v4b{border:2px solid #0984e3;background:#fff;color:#0984e3;padding:8px 20px;border-radius:25px;cursor:pointer;margin-right:10px;font-weight:bold;transition:0.3s;}
.v4b.active{background:#0984e3;color:#fff;}
.v4b:hover:not(.active){background:#e3f2fd;}
.mcq-v4-card{background:#fff;border-radius:15px;padding:35px;margin-bottom:40px;border:1px solid #e1e8ed;box-shadow:0 5px 15px rgba(0,0,0,0.04);}
.card-meta{color:#0984e3;font-weight:800;margin-bottom:20px;letter-spacing:1.5px;font-size:0.95rem;}
.q-stem{font-size:1.25rem;margin-bottom:30px;font-weight:500;line-height:1.7;color:#2d3436;}
.q-opt{display:flex;align-items:center;padding:15px;border:2px solid #f1f2f6;border-radius:12px;margin-bottom:15px;cursor:pointer;transition:all 0.2s ease-in-out;background:#fff;}
.q-opt:hover{border-color:#0984e3;background:#f0f7ff;transform:translateX(5px);}
.q-opt-circle{width:35px;height:35px;border:2px solid #ddd;border-radius:50%;display:flex;align-items:center;justify-content:center;margin-right:20px;font-weight:bold;background:#fafafa;flex-shrink:0;color:#636e72;}
.q-opt.correct{background:#e3fcef;border-color:#00b894;}
.q-opt.correct .q-opt-circle{background:#00b894;color:#fff;border-color:#00b894;}
.q-opt.wrong{background:#fff5f5;border-color:#ff7675;}
.q-opt.wrong .q-opt-circle{background:#ff7675;color:#fff;border-color:#ff7675;}
.q-opt.selected{border-color:#0984e3;background:#e3f2fd;}
.q-opt.selected .q-opt-circle{background:#0984e3;color:#fff;border-color:#0984e3;}
.q-feedback{margin-top:30px;padding:25px;background:#f8f9fa;border-left:6px solid #0984e3;border-radius:8px;}
.feedback-label{font-weight:bold;margin-bottom:15px;font-size:1.2rem;}
.explanation-text{line-height:1.7;color:#444;font-size:1.05rem;}
var v4E={
m:'study',r:new Map(),
setMode:function(m){this.m=m;document.getElementById('v4s').classList.toggle('active',m=='study');document.getElementById('v4e').classList.toggle('active',m=='exam');document.getElementById('v4xa').style.display=m=='exam'?'block':'none';this.reset();},
reset:function(){document.querySelectorAll('.q-opt').forEach(e=>{e.className='q-opt';e.style.pointerEvents='auto';});document.querySelectorAll('.q-feedback').forEach(e=>e.style.display='none');this.r.clear();this.up();},
up:function(){let s=0;this.r.forEach(v=>{if(v===true||v.s==v.c)s++;});const t=document.querySelectorAll('.mcq-v4-card').length;document.getElementById('v4sc').innerText=Math.round((s/t)*100)||0;},
reveal:function(c,s,k){const o=c.querySelectorAll('.q-opt');if(o[k-1])o[k-1].classList.add('correct');if(s!=k && o[s-1])o[s-1].classList.add('wrong');c.querySelector('.q-feedback').style.display='block';const fl=c.querySelector('.feedback-label');fl.innerHTML=s==k?' Correct Answer':' Incorrect';},
finish:function(){this.r.forEach((v,k)=>{this.reveal(document.getElementById('card-'+k),v.s,v.c);});document.querySelectorAll('.q-opt').forEach(e=>e.style.pointerEvents='none');window.scrollTo({top:0,behavior:'smooth'});}
};
document.querySelectorAll('.q-opt').forEach(el=>{
el.onclick=function(){
const q=this.dataset.q,k=this.dataset.correct,s=this.dataset.idx,p=this.closest('.mcq-v4-card');
if(v4E.m=='study') { if(v4E.r.has(q))return; v4E.r.set(q,s==k); p.querySelectorAll('.q-opt').forEach(o=>o.style.pointerEvents='none'); v4E.reveal(p,s,k); }
else { p.querySelectorAll('.q-opt').forEach(o=>o.classList.remove('selected')); this.classList.add('selected'); v4E.r.set(q,{s:s,c:k}); }
v4E.up();
};
});